Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 5237.06 | 459 / 459 | 99% | 71.54 | 1110 / 1118 |
pancreas | 100% | 5500.95 | 327 / 328 | 99% | 54.74 | 177 / 178 |
intestine | 100% | 3153.20 | 962 / 966 | 99% | 88.81 | 522 / 527 |
stomach | 100% | 5835.69 | 359 / 359 | 99% | 66.58 | 282 / 286 |
liver | 100% | 32546.02 | 226 / 226 | 99% | 373.78 | 400 / 406 |
lung | 99% | 5329.10 | 575 / 578 | 98% | 56.44 | 1136 / 1155 |
prostate | 98% | 2661.74 | 241 / 245 | 99% | 83.18 | 498 / 502 |
brain | 95% | 3441.56 | 2523 / 2642 | 99% | 65.13 | 700 / 705 |
esophagus | 98% | 2679.33 | 1415 / 1445 | 96% | 55.42 | 176 / 183 |
uterus | 98% | 2435.63 | 166 / 170 | 95% | 57.78 | 438 / 459 |
skin | 100% | 4850.90 | 1801 / 1809 | 93% | 44.57 | 439 / 472 |
bladder | 95% | 2468.52 | 20 / 21 | 93% | 64.35 | 471 / 504 |
adrenal gland | 99% | 4647.57 | 255 / 258 | 89% | 78.81 | 205 / 230 |
thymus | 94% | 1680.61 | 611 / 653 | 91% | 29.29 | 552 / 605 |
kidney | 96% | 3663.76 | 85 / 89 | 85% | 28.69 | 770 / 901 |
ovary | 92% | 2937.60 | 165 / 180 | 88% | 30.22 | 379 / 430 |
adipose | 100% | 6731.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 62.99 | 29 / 29 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.79 | 1 / 1 |
spleen | 99% | 1672.07 | 239 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2741.54 | 1319 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 50.83 | 43 / 45 |
peripheral blood | 89% | 4858.25 | 831 / 929 | 0% | 0 | 0 / 0 |
heart | 64% | 1263.86 | 548 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 29% | 4.76 | 23 / 80 |
muscle | 28% | 330.73 | 228 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070862 | Biological process | negative regulation of protein exit from endoplasmic reticulum |
GO_0010894 | Biological process | negative regulation of steroid biosynthetic process |
GO_0036316 | Biological process | SREBP-SCAP complex retention in endoplasmic reticulum |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0036315 | Biological process | cellular response to sterol |
GO_1901303 | Biological process | negative regulation of cargo loading into COPII-coated vesicle |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0060021 | Biological process | roof of mouth development |
GO_0032933 | Biological process | SREBP signaling pathway |
GO_0060363 | Biological process | cranial suture morphogenesis |
GO_0006641 | Biological process | triglyceride metabolic process |
GO_0045717 | Biological process | negative regulation of fatty acid biosynthetic process |
GO_0042472 | Biological process | inner ear morphogenesis |
GO_0042474 | Biological process | middle ear morphogenesis |
GO_0006695 | Biological process | cholesterol biosynthetic process |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0032937 | Cellular component | SREBP-SCAP-Insig complex |
GO_0008142 | Molecular function | oxysterol binding |
GO_0140311 | Molecular function | protein sequestering activity |
GO_0005515 | Molecular function | protein binding |
Gene name | INSIG1 |
Protein name | Insulin-induced gene 1 protein Insulin-induced gene protein Insulin-induced gene 1 protein (INSIG-1) |
Synonyms | tcag7.832 hCG_1641980 |
Description | FUNCTION: Oxysterol-binding protein that mediates feedback control of cholesterol synthesis by controlling both endoplasmic reticulum to Golgi transport of SCAP and degradation of HMGCR . Acts as a negative regulator of cholesterol biosynthesis by mediating the retention of the SCAP-SREBP complex in the endoplasmic reticulum, thereby blocking the processing of sterol regulatory element-binding proteins (SREBPs) SREBF1/SREBP1 and SREBF2/SREBP2 . Binds oxysterol, including 25-hydroxycholesterol, regulating interaction with SCAP and retention of the SCAP-SREBP complex in the endoplasmic reticulum . In presence of oxysterol, interacts with SCAP, retaining the SCAP-SREBP complex in the endoplasmic reticulum, thereby preventing SCAP from escorting SREBF1/SREBP1 and SREBF2/SREBP2 to the Golgi . Sterol deprivation or phosphorylation by PCK1 reduce oxysterol-binding, disrupting the interaction between INSIG1 and SCAP, thereby promoting Golgi transport of the SCAP-SREBP complex, followed by processing and nuclear translocation of SREBF1/SREBP1 and SREBF2/SREBP2 . Also regulates cholesterol synthesis by regulating degradation of HMGCR: initiates the sterol-mediated ubiquitin-mediated endoplasmic reticulum-associated degradation (ERAD) of HMGCR via recruitment of the reductase to the ubiquitin ligases AMFR/gp78 and/or RNF139 . Also regulates degradation of SOAT2/ACAT2 when the lipid levels are low: initiates the ubiquitin-mediated degradation of SOAT2/ACAT2 via recruitment of the ubiquitin ligases AMFR/gp78 . . FUNCTION: Mediates feedback control of cholesterol synthesis. . FUNCTION: Mediates feedback control of cholesterol synthesis. . FUNCTION: Mediates feedback control of cholesterol synthesis. . FUNCTION: Mediates feedback control of cholesterol synthesis. . |
Accessions | ENST00000476756.1 C9JSG8 ENST00000340368.9 [O15503-1] A4D2M9 ENST00000344756.8 H7C5L3 ENST00000425172.1 A0A2Z2EKN2 F5H6P3 ENST00000342407.5 [O15503-2] O15503 |